World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2016/04/006855
Date of registration: 22-04-2016
Prospective Registration: Yes
Primary sponsor: Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
Public title: Benefits of human breast milk bank
Scientific title: Impact of human breast milk bank on the mortality and morbidity pattern in a NICU of a tertiary care hospital
Date of first enrolment: 02-05-2016
Target sample size: 230
Recruitment status: Not Yet Recruiting
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=14209
Study type:  Interventional
Study design:  Randomized, Parallel Group Trial
Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Dr Adhisivam   
Address:  Department of Neonatology 6210, II floor JWCH, JIPMER Pondicherry 605006 Pondicherry, PONDICHERRY India
Telephone:
Email: adhisivam1975@yahoo.co.uk
Affiliation:  JIPMER
Name: Dr Adhisivam   
Address:  Department of Neonatology 6210, II floor JWCH, JIPMER Pondicherry 605006 Pondicherry, PONDICHERRY India
Telephone:
Email: adhisivam1975@yahoo.co.uk
Affiliation:  JIPMER
Key inclusion & exclusion criteria
Inclusion criteria: PDHM will be prescribed on priority for intramural and extramural neonates admitted in JIPMER:

• preterm and sick babies

• babies of mothers with postpartum illnesses

• babies whose mothers have lactation failure, till their mothersâ?? milk output improves.

• only neonates of adult mothers will be included

Others:

• Abandoned neonates

• temporary interruption of breastfeeding

• babies whose mother died in the immediate postpartum period


Exclusion criteria: Exclusion criteria

• Neonates who are not inpatients

• Neonates admitted in other hospitals



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Health Condition 1: null- preterm neonates
Intervention(s)
Intervention1: fortified pasteurized donor human milk (PDHM): After counselling, checking suitability for donation and written informed consent, the donor will be sent to the breast milk collection area where breast milk will be collected under supervision of trained staff nurse with hygienic precautions by breastmilk pump. Raw breast milk will be refrigerated immediately. Breast milk from multiple donors will be pooled to ease processing and storage. Donor milk will be pasteurized at the recommended temperature of 62.5ºC for a period of 30 minutes (Pretoria Holder pasteurization method). Microbiological screening of donor milk will be done as soon as possible after pasteurization. The PDHM will be kept in dedicated freezer. Frozen PDHM would be thawed before administering to the neonate. After obtaining informed consent from the parents, neonates satisfying the inclusion criteria will be randomized prior to starting enteral feeds into two groups using computer generated random numbers kept in opaque sealed envelopes. Infants will be assessed for eligibility and randomization within 24 hrs of life. Aseptic precautions will be taken during fortification with PDHM and for fortification, a commercial human milk fortifier[Lactodex HMF, Raptakos Brett, Composition of HMF (per 2g sachet to be mixed in 50 mL EBM) protein â?? 0.2 g, fat â?? 0.1 g, carbohydrate â?? 1.2 g, vitamin A â??730 i.u, vitamin D â?? 250 i.u, calcium â?? 50 mg, phosphate â?? 25 mg, sodium â?? 1.75 mg and energey â?? 6.5 kcal] will be used. Feeds will be started and advanced according to standard NICU protocol. Nutritional supplements (Vitamin D, Calcium, Iron and Vitamin E) will be added in standard doses once full enteral feeding is achieved (100ml/kg/day). Neonates will be fed with orogastric/ nasogas
Primary Outcome(s)
incidence of Necrotizing enterocolitis (NEC)Timepoint: 0-28 days
Secondary Outcome(s)
severity of NEC, incidence of sepsis, mortality, duration of hospital stay, number of days to full enteral feeds and weight gainTimepoint: 0- 28 days
Secondary ID(s)
NIL
Source(s) of Monetary Support
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 19/11/2015
Contact:
Institute Ethics commitee(human studies), JIPMER
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history